The only thing your calculation didn't factor in was the requirement for the short sellers to reacquire their 27m shares. If MSB's share price reaches $5ish the short sellers will need to reacquire.
I agree that if the FDA approve MSB treatment there will not be enough shares to go around towards the end of 2020CY.
Basic calculation below shows the problem new MSB shareholders could face.
Assumptions
top 20 own 73% X 85%
Residual owns 27% X 60%
MSB Trading - 2020, page-1254
-
- There are more pages in this discussion • 21,907 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
-0.005(0.38%) |
Mkt cap ! $1.501B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.181M | 908.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 20121 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10055 | 7 |
View Market Depth
| Last trade - 13.56pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |